Stockreport

Q32 Bio Spotlights Bempikibart AA Data Ahead, Sharpens Focus After Asset Sale at Oppenheimer Confab [Yahoo! Finance]

Q32 Bio Inc.  (QTTB) 
PDF A of the SIGNAL-AA Phase IIa showed statistically significant SALT reductions and apparent durability after dosing cessation, with responses in hard-to-treat patients an [Read more]